期刊文献+

c-Myc和Bin1在人食管鳞状细胞癌组织中的表达及其临床意义 被引量:1

Expression and clinical significance of c-Myc and Bin1 in esophageal squamous cell cancer
下载PDF
导出
摘要 目的:研究人食管鳞状细胞癌(esophageal squamous cell cancer,ESCC)组织及其癌旁组织中c-Myc和Bin1基因的表达情况,并分析其临床意义。方法:收集2013年4月至2014年3月在河北医科大学第四医院胸外科行肿瘤切除并经病理证实的ESCC患者肿瘤组织和相应癌旁组织标本各54例,使用RT-PCR和免疫组织化学法检测ESCC组织和癌旁组织中c-Myc和Bin1基因的mRNA和蛋白的表达。结果:与癌旁组织相比,ESCC组织中的c-Myc mRNA表达水平和蛋白阳性表达率均显著升高[(0.34±0.29)vs(0.17±0.16),P<0.001;55.56%vs 33.33%,P=0.033],Bin1 mRNA表达水平和蛋白阳性表达率均显著降低[(0.25±0.19)vs(0.33±0.20),P<0.001;57.41%vs 84.48%,P=0.007]。ESCC组织中c-Myc mRNA的表达与Bin1 mRNA的表达呈显著负相关关系(r=0.790,P<0.001),c-Myc蛋白表达与Bin1蛋白表达也呈显著负相关关系(P=0.019)。c-Myc和Bin1蛋白表达均与患者TNM分期、肿瘤侵犯深度、分化程度、淋巴结转移相关。结论:人ESCC患者肿瘤组织中c-Myc呈高表达,而Bin1呈低表达,两者表达呈负相关,均与ESCC进展和淋巴结转移有关联。 Objective: To investigate the expression of c-Myc and Bin1 in association with clinical characteristic in patients with esophageal squamous cell cancer( ESCC). Methods: Carcinoma and para-carcinoma tissue specimens were collected from 54 patients with esophageal squamous cell cancer who underwent esophagectomy in Fourth Hospital of Hebei Medical University between April,2013 and March,2014. Bin1 and c-Myc mRNA and protein levels were determined by RT-PCR and immunohistochemistry respectively. The associations between c-Myc and Bin1 protein levels and clinical features were analyzed. Results: Compared with para-carcinoma tissue specimens,carcinoma tissue specimens had significantly higher c-Myc mRNA abundance( 0. 34 ± 0. 29 vs 0. 17 ± 0. 16,P〈 0. 001) and a significantly higher percentage of c-Myc protein-positive tests( 55. 56% vs 33. 33%,P = 0. 033). In contrast,Bin1 mRNA abundance was significantly decreased( P 〈0. 001) in carcinoma tissue specimens( 0. 25 ± 0. 19) as compared with para-carcinoma tissue specimens( 0.33 ±0.20) and the percentage of Bin1 protein-positive tests was significantly lower in carcinoma specimens than in para-carcinoma specimens 57. 41% vs( 84. 48%,P = 0. 007). The abundance of c-Myc mRNA was negatively correlated with Bin1 mRNA abundance( r =- 0. 790,P〈 0. 001) and c-Myc protein level was negatively correlated with Bin1 protein level( P = 0. 019). Both c-Myc and Bin1 proteins were associated with TNM stage,tumor invasion depth,tumor dif-ferentiation and lymph node metastasis. Conclusion: In ESCC tissue,the expression of c-Myc is up-regualted while the expression of Bin1 is down-regulated. Bin1 is negatively correlated with c-Myc at both mRNA and protein levels. The aberrations in both c-Myc and Bin1 is closely associated with tumor invasion and lymph node metastasis of ESCC.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2014年第5期559-564,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81201607) 河北省杰出青年基金资助项目(No.H2014206320) 河北省自然科学基金资助项目(No.H2012206135)~~
关键词 食管鳞状细胞癌 C-MYC基因 Bin1基因 淋巴结转移 esophageal squamous cell cancer c-Myc Bin1 lymph node metastasis
  • 相关文献

参考文献16

  • 1Baba Y, Watanabe M, Shigaki H, et al. Negative lymph-node count is associated with survival in patients with resected esopha- geal squamous Cell carcinoma [ J ]. Surgery, 2013, 153 (2) :234-241.
  • 2Joensuu K, Hagstrfim J, Leidenius M, et al. Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases-el- evated Bmi-1 expressioo in late breast cancer relapses [J]. Vir- chows Arehiv, 2011, 459( 1 ) : 31-39.
  • 3Ge K, Minhas F, Duhadaway J, et al. Loss of heterozygosity and tumor suppressor activity of Binl in prostate carcinoma [ J ]. Int J Cancer, 2000, 86(2) : 155-161.
  • 4Pan K, Liang XT, Zhang HK, et al. Characterization of bridging inte:ator 1 ( BIN1 ) as a potential tumor suppressor and pro:os- tic marker in hepatocellular carcinoma [ J]. Mol Med, 2012, 18 (1) : 507-518.
  • 5Hanahan D, Weinberg RA. Hallmarks of cancer : The next gener- ation [J]. Cell, 2011, 144(5) : 646-674.
  • 6Beroukhim R, Mermel CH, Porter D, et al. The landscape of so- matic copy-number alteration across human cancers [ J]. Nature, 2010, 463(7283) : 899-905.
  • 7Gearhart J, Pashos EE, Prasad MK. Pluripotency redux-advances in stem-cell research [J]. N EngJ Med, 2007, 357(15) : 1469- 1472.
  • 8Miller DM, Thomas SD, Islam A, et al. c-Myc and cancer metab- olism [J]. Clin Cancer Res, 2012, 18(20) : 5546-5553.
  • 9Baudino T A, Mekay C, Pendeville-Samain H, et al. c-Myc is es- sential for vaseulogenesis and angiogenesis during development and tumor progression [ J]. Genes Dev, 2002, 16 (19) : 2530- 2543.
  • 10Knies-Bamforth UE, Fox SB, Poulsom R, et al. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endotheli- al growth factor-dependent mechanism [ J]. Cancer Res, 2004, 64 (18) : 6563-6570.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部